SCHEMBL4429265

SCHEMBL4429265

O=S(=O)(O)C[n+]1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BCHE P06276 7/20 0.36
ACHE P22303 7/20 0.36
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10434886 0.97 BCHE (0.35) BCHEACHEKMT2A
SCHEMBL265850 0.75 BCHE (0.44) BCHEACHE
SCHEMBL19879472 0.74 BCHE (0.36) BCHEACHE
Water SCHEMBL9779611 0.73 BCHE (0.42) BCHEACHE
Sulfuric Acid SCHEMBL8997505 0.72 KMT2A (0.39) ACHEKMT2A
SCHEMBL351087 0.72 BCHE (0.52) BCHEACHE
Sulfuric Acid SCHEMBL4306444 0.72 KMT2A (0.31) BCHEACHEKMT2A
SCHEMBL12296658 0.72 HTT (0.41) KMT2A
Water SCHEMBL1254758 0.70 BCHE (0.50) BCHEACHE
Sulfuric Acid SCHEMBL28430151 0.70 BCHE (0.50) BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101456844-B Room temperature ion liquid containing sulfonic acid ester base side chain as well as preparation method and use thereof LANZHOU CHEM PHYS INST 2010-12-08 CN claimed
US-20090326232-A1 Process for the Preparation of Leukotriene Receptor Antagonist (Montelukast Sodium) AUROBINDO PHARMA LTD (IN) 2009-12-31 US claimed
CN-101456844-A Room temperature ion liquid containing sulfonic acid ester base side chain as well as preparation method and use thereof LANZHOU CHEM PHYS INST (CN) 2009-06-17 CN claimed
WO-2008001213-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF LEUKOTRIENE RECEPTOR ANTAGONIST (MONTELUKAST SODIUM) AUROBINDO PHARMA LIMITED (IN) 2008-01-03 WO claimed
US-9358326-B2 Layered non-fouling, antimicrobial antithrombogenic coatings ARROW INTERNATIONAL, INC. (US) 2016-06-07 US disclosed
US-9056827-B2 Method of synthesizing polyol acetate by using catalyst of ionic liquid heteropoly acid CPC CORPORATION, TAIWAN (TW) 2015-06-16 US disclosed
US-20140045398-A1 LAYERED NON-FOULING, ANTIMICROBIAL ANTITHROMBOGENIC COATINGS SEMPRUS BIOSCIENCES CORPORATION (US) 2014-02-13 US disclosed
US-20130109882-A1 Method of Synthesizing Polyol Acetate by Using Catalyst of Ionic Liquid Heteropoly Acid CPC CORPORATION, TAIWAN (TW) 2013-05-02 US disclosed
US-8308699-B2 Layered non-fouling, antimicrobial antithrombogenic coatings SEMPRUS BIOSCIENCES CORP. (US) 2012-11-13 US disclosed
US-8304171-B2 Plate making method of lithographic printing plate precursor FUJIFILM CORPORATION (JP) 2012-11-06 US disclosed
US-20110245522-A1 Method of Fabricating Fatty Acid Methyl Ester by Using Bronsted Acid Ionic Liquid CPC CORPORATION, TAIWAN (TW) 2011-10-06 US disclosed
US-20110184207-A1 Method of Fabricating Glycol Monoalkyl Ether Acetate Using Acidic Ionic Liquid Catalyst CPC CORPORATION (TW) 2011-07-28 US disclosed
US-20100055607-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE MAKING METHOD THEREOF FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed
US-20090326232-A1 Process for the Preparation of Leukotriene Receptor Antagonist (Montelukast Sodium) AUROBINDO PHARMA LTD (IN) 2009-12-31 US disclosed
US-20090233222-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR FUJIFILM CORPORATION (JP) 2009-09-17 US disclosed
EP-2082875-A1 Lithographic printing plate precursor and plate making method thereof FUJIFILM Corporation (JP) 2009-07-29 EP disclosed
CN-101456844-A Room temperature ion liquid containing sulfonic acid ester base side chain as well as preparation method and use thereof LANZHOU CHEM PHYS INST (CN) 2009-06-17 CN disclosed
WO-2008001213-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF LEUKOTRIENE RECEPTOR ANTAGONIST (MONTELUKAST SODIUM) AUROBINDO PHARMA LIMITED (IN) 2008-01-03 WO disclosed
US-7244854-B2 Method of synthesizing trioxymethylene from formaldehyde by the catalytic action of an ionic liquid LANZHOU INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES (CN) 2007-07-17 US disclosed
US-20070135649-A1 METHOD OF SYNTHESIZING TRIOXYMETHYLENE FROM FORMALDEHYDE BY THE CATALYTIC ACTION OF AN IONIC LIQUID LANZHOU INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES (CN) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326232-A1 Process for the Preparation of Leukotriene Receptor Antagonist (Montelukast Sodium) CYSLTR1, CYSLTR2, LTB4R BCHE 3830/4885ACHE 4682/4885KMT2A 1925/4885
US-20130109882-A1 Method of Synthesizing Polyol Acetate by Using Catalyst of Ionic Liquid Heteropoly Acid HGFAC, HPSE, APEH BCHE 2416/4885ACHE 3185/4885KMT2A 1540/4885
US-20110184207-A1 Method of Fabricating Glycol Monoalkyl Ether Acetate Using Acidic Ionic Liquid Catalyst GMDS, MGLL, GMNN BCHE 93/4885ACHE 758/4885KMT2A 1517/4885
US-20070135649-A1 METHOD OF SYNTHESIZING TRIOXYMETHYLENE FROM FORMALDEHYDE BY THE CATALYTIC ACTION OF AN IONIC LIQUID TST, HPD, PFAS BCHE 2054/4885ACHE 396/4885KMT2A 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.